EDGAR Filing Documents for 0001193125-17-256102

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-17-256102

Filing Date

2017-08-11

Accepted

2017-08-11 17:23:56

Documents

Effectiveness Date

2017-08-11

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d438527ds8.htm	S-8	56978
2	EX-5.1	d438527dex51.htm	EX-5.1	6169
3	EX-23.2	d438527dex232.htm	EX-23.2	1616
4	GRAPHIC	g438527g23g16.jpg	GRAPHIC	3315
	Complete submission text file	0001193125-17-256102.txt		70568

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-219936 | Film No.: 171026137
SIC: 2836 Biological Products, (No Diagnostic Substances)